Welcome to our dedicated page for Cellebrite Di news (Ticker: CLBT), a resource for investors and traders seeking the latest updates and insights on Cellebrite Di stock.
Cellebrite DI Ltd. reports developments in AI-powered digital investigative and intelligence software for public and private sector customers. Its updates cover digital forensics, lawful device access, evidence analysis, investigative collaboration, application security and cloud deployment, including Cellebrite Government Cloud, Guardian Investigate, Genesis and Corellium.
Company news also includes federal cloud-security authorization, product releases, financial results, annual reporting, investor conference participation and product and technology leadership changes. Cellebrite’s software portfolio supports law enforcement agencies, defense and intelligence organizations, enterprises and service providers across cloud, on-premises and hybrid deployments.
Cellebrite DI Ltd. (Nasdaq: CLBT) launched the next generation of Cellebrite Guardian, a secure, SaaS-based solution aimed at enhancing ethical evidence management for law enforcement. Key features include unlimited evidence storage, real-time collaboration, and strict access controls to prevent unintentional sharing of sensitive materials, particularly related to child sexual abuse. The system adheres to Security First and Zero Trust principles, ensuring compliance with UK Cloud Security Standards and SOC2. This innovation aims to streamline investigations and maintain a clear chain of custody.
Cellebrite (NASDAQ: CLBT) announced it will report its Q3 2022 financial results on November 17, 2022, before market open. The management will host a conference call and webcast at 8:30 a.m. ET to discuss these results. Investors can register in advance for the call and access the webcast through the links provided in the announcement. Cellebrite is a leader in Digital Intelligence solutions, enabling effective digital investigations for public and private sectors. The company emphasizes its mission to improve safety and privacy through its technology.
Cellebrite has appointed Ayala Berler Shapira as its new General Counsel, effective immediately. With 27 years of experience in global technology and legal domains, she will lead the company's legal and compliance organization. Previously, she served as Deputy GC of Amdocs, focusing on corporate legal matters and M&A activities. Yossi Carmil, CEO, expressed confidence in her ability to enhance the legal team's infrastructure to meet Cellebrite’s evolving needs. This leadership change is seen as a key step towards supporting the company's strategy and growth objectives.
Cellebrite has partnered with the Lake Jackson Police Department to enhance digital forensics capabilities amid challenges faced by smaller departments. Detective Sergeant Christopher Collins, the sole digital examiner, leverages Cellebrite’s tools such as UFED 4PC, Physical Analyzer, and UFED Cloud to modernize workflows and speed up case resolutions. Collins emphasizes the importance of training for officers and suggests seeking diverse funding sources. This collaboration aims to improve public safety and empower law enforcement with advanced technologies.
Summary not available.
Cellebrite has launched an automated system that integrates investigative analytics, enabling stakeholders to collect, review, and analyze data efficiently. This innovation aims to resolve cases quicker and enhance the workflow for examiners, analysts, and prosecutors by securely storing and decoding evidence. The company's Executive Vice President stated that this system can save hours in the data transfer process, ultimately accelerating justice. Cellebrite, traded on NASDAQ under the symbol CLBT, is committed to enhancing digital investigations.
Cellebrite reported a strong second quarter for 2022, with revenue of $62.6 million, a 6% increase year-over-year, and Annual Recurring Revenue (ARR) of $214 million, reflecting a 35% year-over-year growth. Subscription revenue grew by 20%. However, revenues fell short of expectations due to extended sales cycles and challenges in transitioning to a subscription model. The company has adjusted its full-year revenue forecast to $270-$285 million, down from $285-$300 million. Despite these challenges, management remains optimistic about long-term growth and profitability.
Cellebrite (NASDAQ: CLBT) announced that it will release its second quarter 2022 financial results on August 11, 2022, prior to market opening. A conference call is scheduled for the same day at 8:30 a.m. ET, where management will discuss the financial outcomes. Participants can register in advance to receive dial-in information. Cellebrite aims to enhance Digital Intelligence solutions for public and private sectors, focusing on digital investigations. The company's mission emphasizes protecting lives, accelerating justice, and maintaining privacy globally.
Cellebrite DI Ltd. (NASDAQ: CLBT) and Chainalysis have announced a partnership to enhance digital investigations by integrating cryptocurrency-related tools. This collaboration aims to help law enforcement and corporations address illicit cryptocurrency activities effectively. The solution will provide real-time data and streamline investigation workflows. Additionally, the companies will offer training and expertise in cryptocurrency investigations. The integrated solution is expected to launch in Q3 2022, enhancing tools available for combatting blockchain-related crime.
Cellebrite DI Ltd. (Nasdaq: CLBT) has launched the Cellebrite Physical Analyzer Ultra Series and a SaaS-based Cellebrite Premium, enhancing their digital investigation capabilities. The PA Ultra Series processes larger volumes of data more efficiently, enabling quicker case resolution and supporting cryptocurrency data enrichment. The SaaS version offers a comprehensive cloud-based solution for data management in investigations. These innovations solidify Cellebrite's position as a leader in Digital Intelligence solutions for public and private sectors.